Paper - WANFANG MED ONLINE

You Position: Home > Paper

Guideline for diagnosis and treatment of bacterial vaginosis (2021 revised edition)

( views:838, downloads:2739 )

Author:: No author available

Journal Title:: Chinese Journal of Obstetrics and Gynecology

Issue:: 1

DOI:: 10.3760/cma.j.cn112141-20200717-00583

Key Word:: No keyword available

Abstract：细菌性阴道病（BV）是阴道内乳杆菌减少或消失、兼性厌氧菌及厌氧菌增多导致的常见阴道感染性疾病之一，具有临床表现不典型、复发率高的特点。BV与盆腔炎症性疾病、妇科手术后感染、不良妊娠结局及性传播疾病的发生风险增加相关。BV的诊断主要依据革兰染色Nugent评分标准和临床Amsel标准。BV的治疗主要为口服或局部应用抗厌氧菌药物。BV治疗后反复发作者可适当延长用药疗程。本指南也对妊娠期BV的管理进行了阐述。

Reference

[1]肖冰冰,刘朝晖,廖秦平.影响女性阴道乳酸杆菌数量分布的相关因素分析[J].2008,(6).
[2]孟龄婷,薛艳,岳婷,等.HPV感染与BV、VVC、TV的相关性基于1261例妇科门诊患者的临床研究[J].2016,(10).
[3]中华医学会妇产科学分会感染性疾病协作组.细菌性阴道病诊治指南（草案）[J].2011,(4).
[4]王辰,范爱萍,薛凤霞.《2015年美国疾病控制和预防中心关于阴道炎症的诊治规范》解读[J].2015,(6).
[5]中华医学会妇产科学分会感染性疾病协作组.阴道微生态评价的临床应用专家共识[J].2016,(10).
[6]张岱,刘朝晖,廖秦平,等.中国医院就诊人群阴道微生态状况调查[J].2018,(4).
[7]杜惠兰,魏绍斌,谈勇,等.苦参凝胶临床应用指导意见[J].2020,(8).
[8]Rohit,Chawla.Comparison of Hay's criteria with Nugent's scoring system for diagnosis of bacterial vaginosis.[J].2013,2013.
[9]范爱萍,薛凤霞.细菌性阴道病临床特征及相关危险因素分析[J].2009,(8).
[10]李洁,张崴,赵琳,等.红核妇洁洗液治疗细菌性阴道病临床观察[J].2019,(8).
[11]McClelland RS,Richardson BA,Hassan WM,etc.Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.[J].2008,197(10).
[12]David A. Eschenbach,Sharon Hillier,Cathy Critchlow,etc.Diagnosis and clinical manifestations of bacterial vaginosis[J].1988,158(4).
[13]李东燕,廖秦平.细菌性阴道病发生的危险因素分析[J].2015,(4).
[14]U. FORSUM,T. JAKOBSSON,P. G. LARSSON,etc.An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis[J].2002,110(11).
[15]Emilia H, Koumans,Lauri E, Markowitz,Vijaya, Hogan.Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.[J].2002,35.
[16]Aiping Fan,Yingli Yue,Nv Geng,etc.Aerobic vaginitis and mixed Infections: comparison-of-clinicaland laboratory findings[J].2013,287(2).
[17]王辰,王慧慧,李焕荣,等.《2018欧洲国际性病控制联盟/世界卫生组织关于阴道分泌物（阴道炎症）管理指南》解读[J].2018,(12).
[18]Jack D. Sobel,Daron Ferris,Jane Schwebke,etc.Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis[J].2006,194(5).
[19]Garland SM,Morton AN,Bradshaw CS,etc.High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.[J].2006,193(11).
[20]Sherrard, Jackie,Wilson, Janet,Donders, Gilbert,etc.2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge[J].2018,29(13).
[21]Kenyon,C.,Colebunders,R.,Crucitti,T..The global epidemiology of bacterial vaginosis: A systematic review[J].2013,209(6).
[22].Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis.[J].2009,36(11).
[23]Russo, R.,Karadja, E.,De Seta, F..Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial[J].2019,10(1).
[24].The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis.[J].2009,36(11).
[25].Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.[J].2018,15(2).
[26]Mathys Jacobus Redelinghuys,Marthie Magdaleen Ehlers,Andries William Dreyer,etc.Normal flora and bacterial vaginosis in pregnancy: an overview[J].2016,42(3).